Cutting edge therapy for Psoriasis patients now available in the Caribbean

December 2, 2015

PANAMA CITY, Dec. 2, 2015 /PRNewswire-HISPANIC PR WIRE/ — Psoriasis is a chronic skin disease that affects around 140 million people worldwide. It’s more frequent between the ages of 15 and 25, but may develop at any age and highly impacts the quality of life.

Several types of psoriasis exist, which range from mild to severe and disabling. Plaque psoriasis is the most common form and is known for producing inflammation and scaly patches of thickened skin called “plaques”. It is caused due to a problem in the immunologic system, where white blood cells that normally become activated to fight infections, are in this case activated against the healthy skin cells. The cause of the disease is unknown. The immunologic system is activated and produces inflammatory mediators which are responsible for the skin lesions.

During this process, white blood cells release chemical products called “cytokines”, which produce inflammation, reddening of the skin and make the cutaneous cells move from deeper skin layer to surface at a higher speed than normal, (almost 5 times). These cells accumulate and generate the scaly patches. Psoriatic lesions show the aspect of scales, sometimes with a white silver color, while the skin below is red and if scratched it can bleed. Two specific cytokines are increased in the pathogenesis of psoriasis and produce the inflammatory process of the disease (Interleukin 12 and Interleukin 23).

Ustekinumab is a monoclonal antibody that represents the first of a new class of psoriasis therapies that specifically and selectively targets IL-12/IL-23.

Ustekinumab is now available in the Caribbean, specifically in Aruba, Bahamas, Bermuda, Cayman Islands, Curacao and Jamaica.^[i] Ustekinumab is commercialized under the brand Stelara™.

This therapeutic alternative is the latest generation of psoriasis treatment. With over 3,000 treated patients (in clinical trials) up to 5 years of treatment. The data obtained proves that the treatment is well tolerated and safe.

Clinical trials demonstrated that at least two thirds of the patients obtained a 75% improvement of the psoriasis, in accordance with the Psoriasis Activity Severity Index (PASI 75), after only two doses of Ustekinumab. This innovative treatment has a very convenient dosage regimen when compared with other biological therapies for psoriasis. After 5 years, approximately 80% of the patients treated with Ustekinumab maintain response.

Until recent years, psoriasis was considered a disease limited to the skin. Recent evidence, from important population studies in psoriatic patients, has demonstrated an increase in mortality and a decrease in life expectancy between 3 to 4 years in patients with psoriasis.

On the other hand, the impact of psoriasis notably influences the quality of life, and this is reflected in the increase of different social and psychoactive pathologies, and in the acquisition of unhealthy habits like tobacco and alcohol, favored by low self-esteem, anxiety, depression and the isolation which patients feel subjected to.^[ii]

“Ustekinumab significantly improves the quality of life of patients with moderate to severe psoriasis, as well as their physical and mental functions. After 12 weeks of treatment, patients treated with Ustekinumab present a significant improvement in their mental well-being and their physical condition”, affirmed Dr. Eduardo Franco; Janssen’s Medical Director for Central America and the Caribbean.

The itching and pain, the plaques in their hands and feet may hinder the performance of certain tasks or participation in some activities. Overtime, about 40% of psoriatic patients develop arthritis. “The most severe cases of psoriasis may even generate immobility of the patient. Some patients compare the reduction of their physical activities to the ones generated by other diseases as cancer or heart diseases”, pointed out Dr. Jose Antonio Herrera, Immunology Medical Manager for Janssen.

About Janssen

Janssen is a Company dedicated to the research of providing innovative products that help protect and improve the life of people, and face and solve the most important and unresolved medical needs of our times, in the areas of oncology, immunology, neurosciences and infectious, cardiovascular and metabolic diseases.

Across the different companies of the Johnson & Johnson group, our people are united in the passionate pursuit of solutions through science, in benefit of the patients.

Present in over 50 countries, we share the commitment of the founders of the Company, of innovating in ideas, products and services for the patients of the whole world.

^{[i] Ustekinumab was approved by the following Health Authorities:
Aruba: Drug Registration Board,
Curacao; Drug Registration Board
Jamaica: Ministry of Health.
Cayman Islands, Bahamas and Bermuda are not regulated countries.}

^{[ii] 2009 Latin American Psoriasis Consensus, treatment guides, Latin American Psoriasis Society}

Fact Sheet Psoriasis

Psoriasis is a chronic disease that affects over 140 million people worldwide.
It presents itself more frequently between the ages of 15 and 25, but may develop at any age and highly impacts the quality of life.
The main cause for this disease is unknown. The immunologic system is activated and produces inflammatory mediators which stimulated white cells and infiltrate the skin layers. The deep layer cells move to the outer layer of the skin at least 5 time faster than usual, and this produces the characteristic plaque of the psoriasis.
There are several clinical forms of the disease, plaque psoriasis being the most common form. It is known for producing inflammation and scaly patches of thickened skin called “plaques”.
Moderate to severe plaque psoriasis, notably influences the quality of life. Severe cases of psoriasis may even generate immobility of the patient.
Some patients compare the reduction of their physical activities to the ones generated by other diseases such as cancer or heart disease.
Ustekinumab is now available in the Caribbean, specifically in Aruba, Bahamas, Bermuda, Caiman Islands, Curacao and Jamaica.[i] Ustekinumab is commercialized under the brand Stelara™.
Clinical trials with over 3,000 patients treated with Ustekinumab have demonstrated its efficacy. At least two thirds of the patients obtained a 75% improvement of the Psoriasis Activity Severity Index.
After 5 years, approximately 80% of the patients treated with Ustekinumab maintain response.

^{[i] Ustekinumab was approved by the following Health Authorities:
Aruba: Drug Registration Board,
Curacao; Drug Registration Board
Jamaica: Ministry of Health.
Cayman Islands, Bahamas and Bermuda are not regulated countries.}

Spotlight – Dr. Owusu Kizito Interviewed on New York Stock Exchange Television, NY

December 2, 2015

0

NEW YORK, Dec. 2, 2015 /PRNewswire-HISPANIC PR WIRE/ — The state of the world’s economy appears to be improving given that macroeconomic risks have declined steadily over the years since the big recession. There are several complex forces shaping macroeconomic evolutions around the world. Accordingly, Dr. Owusu Kizito, Chief Executive Officer (CEO) of Investigroup Inc. (Investigroup.com) was invited by the prestigious New York Stock Exchange (NYSE), the world financial center and most powerful finance authority to weigh in on the state of the economic and business activities in the United States and around the world. The host was Mike Norman, an economist and a very well known news anchor at Wall Street.

Photo – http://photos.prnewswire.com/prnh/20151126/291315
Video – http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/291316-Kizito-Wall-Street-Interview.mp4

Asked how the economic conditions in the United States is doing so far, Dr. Kizito acknowledged that the economy is doing much better since the great recession of 2008/2009 because of a bit higher consumer confidence coupled with banks and financial institutions making credit and loan facilities available to small to medium sized companies to foster growth. With regards to up and coming markets like Ghana and Africa, Dr. Kizito was very optimistic about investment and business opportunities in Ghana. While the interviewer Mr. Norman acknowledged that doing business in Africa can be murky, Dr. Kizito touted Ghana as a very investor-friendly country in Sub-Sahara Africa that is truly open for real investments from capable and willing investors. “The Chinese are all over Ghana jumping in on business opportunities, especially in the emerging Crude Oil business,” according to Professor Kizito, a college professor and successful entrepreneur on his relationships with some investors from China. He therefore urged Wall Street investors to visit the trade departments of the embassies of Ghana to receive the correct and verifiable information on investment opportunities in Ghana.

To listen to the full live interview, please check this link
http://pitbulleconomics.com/Images/Kizito2.mp4

A Known Fact

Dr. Owusu Kizito has a track record of being a dynamic, results-driven professional. He has close to twenty years of experience in consulting, banking, financial analysis, project management, and process improvement. In addition, he has an extensive background as analytic expert regarding the calculus of decision-making, and problem solving. Dr. Owusu Kizito is the President and CEO of Investigroup companies. Apart from being a financial and housing counseling expert, he is also a successful writer, tax expert and a published author.

He launched a book entitled “LIVED EXPERIENCES OF HOME FORECLOSURES CONSEQUENCES ON MENTAL AND PHYSICAL HEALTH.“

The launching also included a Collaborative Cultural Exhibition between China and Ghana, also jointly organized by Dr. Owusu Kizito, the Ghana permanent mission to the United Nations and his Chinese partner Mr. Andy Lin of the United Nations Commutech Group. This was in recognition and celebration of the 70th Anniversary of the United Nations and to promote cross-cultural exchange which occurred at United Nations Headquarters, New York from July 13 to July 24, 2015.

Contact:

Dr Owusu Kizito
1-908-977-7320
[email protected]

FIBRA Prologis Announces Sale of 340,000 Square Foot Property

December 2, 2015

0

MEXICO CITY, Dec. 2, 2015 /PRNewswire-HISPANIC PR WIRE/ — FIBRA Prologis (BMV: FIBRAPL14), the leading owner and operator of Class-A industrial real estate in Mexico, today announced it has completed the sale of a 340,000 square foot property in Guadalajara to its current tenant.

Logo – http://photos.prnewswire.com/prnh/20140703/124469

Net cash proceeds from the sale will be used for the partial repayment of the line of credit.

“The sale of this asset to the current tenant represents an opportunity for our investors because it allows us to maximize the value of this highly specialized industrial building,” said Jorge Girault, senior vice president, Finance, Prologis Mexico. “This sale will further enhance our liquidity, as net proceeds will be used to pay down our line of credit.”

As of September 30, 2015, FIBRA Prologis owned approximately 5.9 million square feet of logistics and distribution space in its Guadalajara market and 31.6 million square feet throughout Mexico.

ABOUT FIBRA PROLOGIS
FIBRA Prologis is the leading owner and operator of Class-A industrial real estate in Mexico. As of September 30, 2015, FIBRA Prologis comprised 185 logistics and manufacturing facilities in six industrial markets in Mexico totaling 31.6 million square feet (2.9 million square meters) of gross leasable area.

FORWARD-LOOKING STATEMENTS
The statements in this release that are not historical facts are forward-looking statements. These forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which FIBRA Prologis operates, management’s beliefs and assumptions made by management. Such statements involve uncertainties that could significantly impact FIBRA Prologis financial results. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future — including statements relating to rent and occupancy growth, acquisition activity, development activity, disposition activity, general conditions in the geographic areas where we operate, our debt and financial position, are forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. Some of the factors that may affect outcomes and results include, but are not limited to: (i) national, international, regional and local economic climates, (ii) changes in financial markets, interest rates and foreign currency exchange rates, (iii) increased or unanticipated competition for our properties, (iv) risks associated with acquisitions, dispositions and development of properties, (v) maintenance of real estate investment trust (“FIBRA”) status and tax structuring, (vi) availability of financing and capital, the levels of debt that we maintain and our credit ratings, (vii) risks related to our investments (viii) environmental uncertainties, including risks of natural disasters, and (ix) those additional factors discussed in reports filed with the “Comision Nacional Bancaria y de Valores” and the Mexican Stock Exchange by FIBRA Prologis under the heading “Risk Factors.” FIBRA Prologis undertakes no duty to update any forward-looking statements appearing in this release.

Non-Solicitation – Any securities discussed herein or in the accompanying presentations, if any, have not been registered under the Securities Act of 1933 or the securities laws of any state and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements under the Securities Act and any applicable state securities laws. Any such announcement does not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein or in the presentations, if and as applicable.

American Honda Reports November Car and Truck Sales

December 1, 2015

0

2016 Honda Pilot sales climb 19 percent as American Honda reports November sales results.

TORRANCE, California, Dec. 1, 2015 /PRNewswire-HISPANIC PR WIRE/ — American Honda Motor Co., Inc. today reported November sales of 115,441 Honda and Acura vehicles, a decrease of 5.2 percent in a month with two fewer selling days and one less weekend vs. a record-setting November 2014. Honda Division sold 103,197 units, with car sales reaching 53,900 and truck sales totaling 49,297 for the month. Acura sales totaled 12,244, with sedan sales of 4,461 and trucks reaching 7,783 units in November.

Honda

Strong sales of the all-new Pilot and core Honda models kept Honda on track for an all-time annual sales record, with the Accord, Civic and CR-V on course to reach a combined one million units in sales for the third consecutive year.

Pilot sales climbed strongly, rising 19 percent on sales of 10,975 units putting the all-new Pilot on the verge of its best sales year since 2006.
Civic posted an 8.6 percent November increase on sales of 25,050 units, even as the production ramp up of the 2016 Civic Sedan continues at Honda plants in North America.
Accord posted a November increase of 1.2 percent to 25,566 units, boosting YTD 2015 sales to 320,501 units.
CR-V continued on pace as the industry’s best-selling SUV, with sales of 25,931 units in November pushing its 2015 total over the 300,000-unit mark for the third consecutive year.

“It is incredibly gratifying to see our customers embrace the all-new Pilot and Civic,” said Jeff Conrad, senior vice president and general manager of the Honda Division. “We are going to race to the finish in the effort to earn a record number of new customers this year.”

Acura
Acura truck sales remain on pace for a record year with combined sales of MDX and RDX approaching the 100,000-unit mark for 2015, while Acura sedan sales are up more than 20% in 2015, topping 60,000 units for the first time since 2013.

Acura’s athletic RDX set a new November record, climbing 7.4 percent on sales of 3,691 vehicles.
TLX sales of 43,572 units through the first 11 months of 2015 has now nearly tripled the 2014 combined sales total of the TLX and the outgoing TL and TSX models it replaced.

“With the Acura brand on track for our fifth consecutive year of increased sales and our best annual sales total since 2007 we continue to build strong momentum toward next year’s celebration of Acura’s 30^th anniversary,” said Jon Ikeda, vice president and general manager of the Acura division. “We also recognize and embrace the challenges of an ultra-competitive luxury market as we sharpen our portfolio with products like the technologically advanced NSX and continue to build the brand with highly desirable vehicles throughout the lineup.”

	American Honda Vehicle Sales for November 2015
			Month-to-Date				Year-to-Date
			November 2015	November 2014	DSR** % Change	MoM % Change	November 2015	November 2014	DSR** % Change	YoY % Change
	American Honda Total		115,441	121,814	3.0%	-5.2%	1,435,658	1,403,591	2.6%	2.3%
	Total Car Sales		58,361	61,430	3.3%	-5.0%	738,111	768,719	-3.6%	-4.0%
	Total Truck Sales		57,080	60,384	2.7%	-5.5%	697,547	634,872	10.3%	9.9%
	Honda Total	Car Sales	53,900	55,222	6.1%	-2.4%	675,809	717,312	-5.4%	-5.8%
	Honda Total	Truck Sales	49,297	51,735	3.6%	-4.7%	599,507	536,245	12.2%	11.8%
	Acura Total	Car Sales	4,461	6,208	-21.9%	-28.1%	62,302	51,407	21.6%	21.2%
	AcuraTotal	Truck Sales	7,783	8,649	-2.2%	-10.0%	98,040	98,627	-0.2%	-0.6%
	Total Domestic Car Sales		55,655	60,651	-0.3%	-8.2%	729,135	731,833	-0.0%	-0.4%
		Honda Division	51,314	54,688	2.0%	-6.2%	668,904	689,876	-2.7%	-3.0%
		Acura Division	4,341	5,963	-20.9%	-27.2%	60,231	41,957	44.1%	43.6%
	Total Domestic Truck Sales		57,080	60,384	2.7%	-5.5%	697,542	634,872	10.3%	9.9%
		Honda Division	49,297	51,735	3.6%	-4.7%	599,502	536,245	12.2%	11.8%
		Acura Division	7,783	8,649	-2.2%	-10.0%	98,040	98,627	-0.2%	-0.6%
	Total Import Car Sales		2,706	779	277.6%	247.4%	8,976	36,886	-75.6%	-75.7%
		Honda Division	2,586	534	426.4%	384.3%	6,905	27,436	-74.7%	-74.8%
		Acura Division	120	245	-46.8%	-51.0%	2,071	9,450	-78.0%	-78.1%
	Total Import Truck Sales		0	0	0.0%	0.0%	5	0	0.0%	0.0%
		Honda Division	0	0	0.0%	0.0%	5	0	0.0%	0.0%
		Acura Division	0	0	0.0%	0.0%	0	0	0.0%	0.0%
MODEL BREAKOUT BY DIVISION
	Honda Division Total		103,197	106,957	4.9%	-3.5%	1,275,316	1,253,557	2.1%	1.7%
		* ACCORD	25,566	25,275	9.9%	1.2%	320,501	356,785	-9.8%	-10.2%
		* CIVIC	25,050	23,060	18.1%	8.6%	302,588	300,644	1.0%	0.6%
		CR-Z	236	188	36.4%	25.5%	2,757	3,338	-17.1%	-17.4%
		FCX CLARITY	0	0	0.0%	0.0%	0	1	-100.0%	-100.0%
		* FIT	3,018	6,421	-48.9%	-53.0%	48,527	52,890	-7.9%	-8.2%
		INSIGHT	30	278	-88.3%	-89.2%	1,436	3,654	-60.6%	-60.7%

		CROSSTOUR	527	955	-40.0%	-44.8%	8,491	10,939	-22.1%	-22.4%
		* CR-V	25,931	32,378	-12.9%	-19.9%	314,462	302,650	4.3%	3.9%
		HR-V	3,505	0	0.0%	0.0%	37,232	0	0.0%	0.0%
		ODYSSEY	8,356	8,639	5.1%	-3.3%	115,936	112,370	3.5%	3.2%
		PILOT	10,975	9,228	29.3%	18.9%	122,868	97,378	26.6%	26.2%
		RIDGELINE	3	535	-99.4%	-99.4%	518	12,908	-96.0%	-96.0%

		*** Memo: Accord FHEV	288	1,094	-71.4%	-73.7%	10,841	12,744	-14.6%	-14.9%
		Memo: Accord PHEV	1	43	-97.5%	-97.7%	63	386	-83.6%	-83.7%
		Memo: Civic Hybrid	239	432	-39.9%	-44.7%	4,624	4,594	1.0%	0.7%
		Memo: Fit EV	0	5	-100.0%	-100.0%	1	375	-99.7%	-99.7%
	Acura Division Total		12,244	14,857	-10.4%	-17.6%	160,342	150,034	7.3%	6.9%
		ILX	1,353	1,652	-11.0%	-18.1%	16,571	16,124	3.1%	2.8%
		RLX / RL	120	225	-42.0%	-46.7%	2,036	3,180	-35.7%	-36.0%
		TL	1	78	-98.6%	-98.7%	88	10,540	-99.2%	-99.2%
		TLX	2,987	4,233	-23.3%	-29.4%	43,572	15,293	185.9%	184.9%
		TSX	0	20	-100.0%	-100.0%	35	6,270	-99.4%	-99.4%

		MDX	4,092	5,210	-14.6%	-21.5%	51,954	58,842	-11.4%	-11.7%
		RDX	3,691	3,436	16.8%	7.4%	46,084	39,709	16.5%	16.1%
		ZDX	0	3	-100.0%	-100.0%	2	76	-97.4%	-97.4%

		*** Memo: ILX Hybrid	0	10	-100.0%	-100.0%	22	370	-94.0%	-94.1%
		Memo: RLX Hybrid	13	37	-61.8%	-64.9%	234	104	125.8%	125.0%
		Memo: TSX Wagon	0	2	-100.0%	-100.0%	2	637	-99.7%	-99.7%
	Selling Days		23	25			280	281
	**** Hybrid		807	2,082	-57.9%	-61.2%	19,977	25,190	-20.4%	-20.7%

* Honda and Acura vehicles are made of domestic & global sourced parts

** Daily Selling Rate

*** Memo line items are included in the respective model total

**** Hybrid includes FHEV, PHEV, CR-Z, Civic Hybrid, Insight, ILX Hybrid, RLX Hybrid and RLX Sport Hybrid

Photo – http://photos.prnewswire.com/prnh/20151201/292188
Logo – http://photos.prnewswire.com/prnh/20100923/HONDALOGO

El Salvador Conducts First Investment Forum In New York

December 1, 2015

0

NEW YORK, Dec. 1, 2015 /PRNewswire-HISPANIC PR WIRE/ — El Salvador Export and Investment Attraction Agency (PROESA) conducted its first Investment Forum, El Salvador: Opportunities Beyond Expectations, with invited guests from a cross-section of the business and investment communities in Manhattan and the surrounding metropolitan area. A panel of Salvadorian officials and a US businessman discussed the opportunities and advantages of doing business and investing in El Salvador.

Speaking at the forum Mr. Sigfrido Reyes, President of PROESA said: “More than 50 companies from all around the world have already established a home for their operations in El Salvador. We have every expectation that it will continue to grow.”

Referencing the benefits of commerce in El Salvador, Reyes continued: “The people of El Salvador are friendly and gracious in their hospitality.” El Salvador, located in the middle of the Americas, has adopted the US dollar – considered a major factor for investors. Citing the issue of safety, security, and overall stability of El Salvador, Reyes said: “We have fought and won corruption, have worked vigorously to promote economic growth, and today we offer a country that is ready, in all aspects, to be your partner.”

Speaking specifically to the issue of economics, Carolina Vides, Investment and Export Manager for PROESA, said: “It all starts with investment laws. El Salvador offers attractive tax incentives which guaranty investors a secure environment.” The country has begun to attract foreign direct investors (FDI), a statistic supported by the fact that it has more foreign direct investors than any other country in the region.

Phil Pedone, panelist and US businessman with operations in El Salvador, believes El Salvador is an outstanding place to conduct business, stating: “They have free trade agreements with 42 countries, and taxes are very favorable for foreign investors.” According to Pedone, profits from their Salvadorian business have allowed them to make investments that have helped grow their business both in US and El Salvador.

Salvadoran UN Ambassador, H.E. Ruben Zamora, in closing, stated: “We have been speaking today of all the advantages of investing in El Salvador. A major factor of foreign investors joining us in El Salvador is that it creates opportunities for everyone; we have created an environment for businesses to invest and grow with El Salvador.”

About PROESA:
Founded in 2000, PROESA is El Salvador’s Export and Investment Attraction Agency. PROESA is an independent government agency whose mission it is to improve the lives of the people of El Salvador through the promotion of exports, investments and public private partnerships. And to, increase national productivity by the creation employment opportunities and enhanced national development.

For more information about EL SALVADOR and PROESA please contact [email protected].

(Español) El escape de ‘El Chapo’ Guzmán, Lionel Messi, y Jennifer López entre lo más buscado en Yahoo en Español en el 2015

December 1, 2015

0

Sorry, this entry is only available in Español.

The makers of the HERDEZ® and DONA MARIA® Brands Partner to Bring Las Posadas Celebrations to Community and Children

December 1, 2015

0

ORANGE, California, Dec. 1, 2015 /PRNewswire-HISPANIC PR WIRE/ — For the first time ever, the makers of the HERDEZ^® brand, the No. 1 salsa brand in Mexico and the makers of the DONA MARIA^®brand, the No. 1 mole brand in Mexico, are partnering to bring Las Posadas celebrations to local communities and children in Los Angeles, Calif. Las Posadas or the inns, is a nine-day celebration taking place from Dec. 16-24. The Mexican holiday features pilgrims on candlelit processions filled with singing and cheer culminating in festivities and traditional foods offered by an innkeeper. This year the two brands will kick-off the holiday by hosting a free posada for the local community on Wednesday, Dec. 16 from 5:30-7:30 p.m. at the El Paseo Inn restaurant at Olvera Street. The community will enjoy a fun-filled celebration with food, music and live mariachi. To further celebrate, HERDEZ^® and DONA MARIA^® brands will gift a $10,000 cash sum donation and gifts to Los Angeles based Para Los Ninos, a non-profit organization that battles poverty and promotes academic success for disadvantaged children. The donation will serve to fund Para Los Ninos’ Felices Fiestas, a holiday festival that provides food and gifts for local families in need.

HERDEZ(R) and DOÑA MARÍA(R) Brands Partner to Bring Las Posadas Celebrations to Community and Children; Brands to Donate $10K and Gifts to Para Los Ninos Organization

“Para Los Ninos is thankful to receive such a generous donation from the HERDEZ^® and DONA MARIA^® brands,” said Martine Singer, Para Los Ninos CEO. “Partnerships such as these allow us to continue providing our kids with a safe learning environment in which to thrive.”

HERDEZ^® and DONA MARIA^® brands will also be coordinating a gift drop-off campaign to further benefit Para Los Ninos’ Felices Fiestas. Wrapped or un-wrapped presents can be dropped off at El Paseo Inn restaurant located at 11 Olvera Street in Los Angeles, Calif. from Dec. 1-16.

“Para Los Ninos’ Felices Fiestas celebrates and rewards the success of our children through this holiday festival, ensuring they are recognized and don’t walk away empty handed this holiday season,” said Gilberto Gutierrez, senior brand manager for HERDEZ^® brand a division of MegaMex Foods. HERDEZ^® brand is excited to team up with DONA MARIA^® brand for the first time ever, working together towards worthwhile causes such as these.”

“Las Posadas is a perfect time to warm our kitchens with savory flavors and celebrate with family, friends, food, salsa and mole,” said Elisa Velazquez, brand manager for DONA MARIA^® brand at MegaMex Foods. “DONA MARIA^® brand is honored to be a part of this longstanding tradition, and through this new partnership with HERDEZ^®brand, offer our community memorable holiday moments.”

For more information on Las Posadas events visit: www.herdeztraditions.com/las-posadas. Follow HERDEZ^® and DONA MARIA^® brands via social media on Facebook and Instagram @HERDEZTraditions, and on Twitter @HERDEZBrand. For a chance to win prizes, join the conversation via #MisPosadas.

About the HERDEZ® Brand

HERDEZ® salsa is made the authentic way, using fresh ingredients like tomatoes, onions, chile peppers and cilantro. Today, HERDEZ® Salsa is the No.1 selling salsa brand in Mexico and a growing staple in homes in the United States. HERDEZ® authentic Mexican products are available nationwide at major grocery stores. Visit www.herdeztraditions.com for more information.

About the DONA MARIA® Brand

When it comes to world-famous mole pastes and tender nopalitos, DONA MARIA® brand has been Mexico’s favorite brand for over 65 years. Made with rich, flavorful ingredients such as fiery ancho chiles, pasilla chiles, peanuts, chocolate, hearty pumpkin seeds and a blend of signature Mexican spices DONA MARIA® mole features a smooth, slow-cooked flavor, making it the No.1 mole brand in Mexico today. Based on authenticity, this robust sauce is remarkably easy to use delivering a unique homemade flavor to any dish. DONA MARIA® authentic Mexican products are available nationwide at major grocery stores.

About Para Los Ninos

Since 1980, Para Los Ninos has helped children and families succeed in school and life. Each year PLN serves 7,500 children and families at 11 sites in the most impoverished neighborhoods in Los Angeles. Para Los Ninos schools immerse children in rigorous learning and enriching environments, and offer families skills that support academic achievement and financial stability. The organization utilizes novel and innovative teaching methodologies to promote student achievement, along with coordinated case management to bring mental health and support services to all members of the community. By combining school-day education with valuable life services, Para Los Ninos gives children the opportunities to combat the achievement gap, escape poverty, and achieve success in school and in life.

Photo – http://photos.prnewswire.com/prnh/20151201/292280

Combate Americas Hits Hollywood!

December 1, 2015

0

NEW YORK, Dec. 1, 2015 /PRNewswire-HISPANIC PR WIRE/ — Combate Americas, the first-ever U.S. Hispanic Mixed Martial Arts (MMA) sports franchise founded by Ultimate Fighting Championship (UFC) co-creator Campbell McLaren, today announced that it will make its debut in Los Angeles, Calif. with a stellar, nine-bout fight card at Florentine Gardens, live on NBC UNIVERSO, the modern entertainment and sports cable channel for Latinos, on Wednesday, Dec. 16 at 11 p.m. ET/8 p.m. PT.

“This event represents Combate Americas coming of age, and presenting a lineup that is second to none with a collection of the brightest up-and-coming Hispanic fighters in the U.S.,” said McLaren.

Priced from $40, tickets for “Premier Insurance Services and Aspira Mas Present Combate Americas: Road To The Championship Hollywood,” are on sale at www.HollywoodFightNight.com.

In the bantamweight (135 pounds) main event of the live, four-fight telecast on NBC UNIVERSO, John “Sexy Mexy” Castaneda, fresh off his victory at the inaugural “Combate Americas: Road To The Championship” event in Las Vegas, Nev. on September 17, will square off with fellow striking sensation Federico “Kiko” Lopez.

The 23-year-old Castaneda (8-2), a seasoned striker who hails from Mankato, Minn., earned his third consecutive victory in the form of a unanimous decision over Justin Governale in the Combate Americas cage.

A 31-year-old member of Team Quest, Lopez (10-5) of Murrieta, Calif. is riding a five fight win streak, with four of those victories having come by way of either (T)KO or submission.

In the bantamweight co-main event, Combate Americas reality television series star and power puncher Ricky “El Gallero” Palacios will square off with dangerous scrapper Anthony Paredes of Murrieta.

Palacios (5-1), a 28-year-old resident of Mission, Texas who also boasts an unblemished professional boxing record of 2-0-1, scored a thunderous, first round (1:00) KO on Benji Gomez with a head kick at the “Combate Americas: Road To The Championship” event on September 17, while the 26-year-old Paredes, another member of Team Quest, is looking to return to the win column after suffering a loss in July that snapped a two-fight win streak.

In a featured women’s atomweight (105 pounds) attraction on the live telecast, Kyra “Mogwai” Batara will collide with “Lightning” Liz McCarthy.

Fighting out of Las Vegas, Batara (3-3) is a 21-year-old protege of Brazilian Jiu-Jitsu guru Eddie Bravo. During the “Combate Americas: Road To The Championship” event in Las Vegas, Batara pulled off a stunning upset win via unanimous decision over Nicdali Rivera-Calanoc, a former world championship challenger with five times as many professional bouts as Batara.

The 29-year-old McCarthy (2-3), also fighting out of Las Vegas, is a four-time veteran of Invicta FC, the world’s premier all-women’s MMA league. Prior to her professional debut at Invicta FC 2 where she defeated Jessica Philippus by way of first round (5:00) TKO (doctor stoppage) on July 28, 2012, McCarthy amassed a perfect, 6-0 record as an amateur.

The live NBC UNIVERSO telecast will kick off with a featherweight (145 pounds) matchup between Urijah Faber protege and prolific finisher Erick Sanchez (5-2) of Sacramento, Calif. and fellow rising star “Ruthless” Rudy Morales (3-3) of Las Vegas.

The complete, five-bout preliminary card for “Combate Americas: Road To The Championship Hollywood” will be announced soon.

Doors at Florentine Gardens open at 5 p.m. PT for the event, and the first preliminary bout will begin at 6 p.m.

ABOUT COMBATE AMERICAS
Combate Americas, LLC. is the first U.S. Hispanic Mixed Martial Arts (MMA) sports franchise in history, designed to build Latino fighting champions and serve Hispanic fans, one of the world’s most avid groups of prize fighting enthusiasts. The Combate Americas franchise includes reality TV programming, live events and mobile programming. The company’s CEO, Campbell McLaren, is universally recognized as the co-founder/co-creator of the Ultimate Fighting Championship (UFC). New York Magazine described McLaren as “the marketing genius behind the UFC” and Yahoo! Sports proclaimed that he “knows more about the sport than just about anyone in it today.” With an unprecedented product and a blue-chip ownership and management team, Combate Americas is poised to break new ground and bring about a new era in world championship level MMA competition.

About NBC UNIVERSO:
NBC UNIVERSO (www.nbcuniverso.com) is a modern entertainment and sports cable channel for Latinos, bringing the world’s top sports franchises and edgy programming to more than 40 million households in the U.S. As one of the most widely available modern cable channels for U.S. Latinos, NBC UNIVERSO delivers a thrilling mix of exclusive sports action – including FIFA World Cup™, Liga MX, Premier League, NASCAR Mexico Series, NFL and The 2016 Rio Olympics – along with signature series, blockbuster movies, music, must-see live events and strategic acquisitions, on TV, online and mobile devices. NBC UNIVERSO is part of NBCUniversal Telemundo Enterprises, a division of NBCUniversal (www.nbcuniversal.com), one of the world’s leading media and entertainment companies. NBCUniversal is a subsidiary of Comcast Corporation (www.comcastcorporation.com). To find the NBC UNIVERSO channel number in your area, please visit www.nbcuniverso.com/encuentralo.

Logo – http://photos.prnewswire.com/prnh/20150716/237654LOGO

(Español) Lil Wayne anuncia la gira THE DEDICATION TOUR

December 1, 2015

0

Sorry, this entry is only available in Español.

Kia Motors America Records Best November In Company History And Sells Six Millionth Vehicle In The U.S.

December 1, 2015

0

IRVINE, California, Dec. 1, 2015 /PRNewswire-HISPANIC PR WIRE/ — Propelled by the sale of its six millionth vehicle in the U.S. since arriving in 1994, Kia Motors America’s (KMA) year-long momentum continued with best-ever November sales of 45,553 vehicles, a 1.4-percent increase over the same period last year. The brand’s seventh straight monthly sales record was led by the Optima and Soul, with 13,048 and 10,045 units sold, respectively.

Photo – http://photos.prnewswire.com/prnh/20151201/292222

“Kia has outpaced the industry all year, and with our ‘Holidays On Us’ sales event in place throughout November customers visited our showrooms in record numbers to discover the new Kia,” said Michael Sprague, chief operating officer and EVP, KMA. “Kia continues to grow and mature at a rapid rate, and surpassing the six million vehicles mark as we push toward a strong finish to the year is the latest example of how far this brand has come in a very short period of time.”

About Kia Motors America

Kia Motors America (KMA) is the marketing and distribution arm of Kia Motors Corporation based in Seoul, South Korea. KMA proudly serves as the “Official Automotive Partner” of the NBA and LPGA and set an all-time annual sales record in 2014, surpassing the 500,000 unit mark for the third consecutive year. KMA offers a complete line of vehicles, including the rear-drive K900¹ flagship sedan, Cadenza premium sedan, Sorento CUV, Soul urban passenger vehicle, Soul Electric Vehicle², Sportage compact CUV, Optima midsize sedan, Optima Hybrid, the Forte compact sedan, Forte5 and Forte Koup, Rio and Rio 5-door subcompacts and the Sedona midsize multi-purpose vehicle, through a network of more than 765 dealers across the United States. Kia’s U.S. manufacturing plant in West Point, Georgia, builds the Optima* and Sorento* and is responsible for the creation of more than 15,000 plant and supplier jobs.

Information about KMA and its full vehicle line-up is available at www.kia.com. For media information, including photography, visit www.kiamedia.com. To receive custom email notifications for press releases the moment they are published, subscribe at www.kiamedia.com/us/en/newsalert.

* The Sorento and Optima GDI (EX, SX & Limited and certain LX Trims only) are assembled in the United States from U.S. and globally sourced parts.

	MONTH OF NOVEMBER		YEAR-TO-DATE
Model	2015	2014	2015	2014
Rio	898	2,088	22,745	34,009
Forte	5,010	5,047	73,508	64,030
Optima	13,048	12,707	145,732	147,193
Cadenza	847	482	6,745	8,719
K900	228	69	2,362	1,237
Sportage	4,211	3,261	47,695	39,647
Sorento	9,023	8,598	103,377	92,832
Sedona	2,243	3,538	34,439	11,570
Soul	10,045	9,146	134,974	135,410
Total	45,553	44,936	571,577	534,647

___________________________________

¹ K900 available in select trims and in select markets with limited availability.

² Soul EV in select markets with limited availability.